Özcan Met

Özcan Met

Visiting associate professor, Gæstelektor

Member of:

    ORCID: 0000-0002-3256-7592

    Publication year:
    All
    71 - 74 out of 74Page size: 10
    1. 2008
    2. Published

      Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients.

      Trepiakas, R., Pedersen, Anders Elm, Met, Özcan, Hansen, M. H., Berntsen, A. & Svane, I. M., 2008, In: Vaccine. 26, 23, p. 2824-32 8 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. 2006
    4. Published

      The effect of a therapeutic dendritic cell-based cancer vaccination depends on the blockage of CTLA-4 signaling.

      Met, Özcan, Wang, M., Pedersen, Anders Elm, Nissen, Mogens Holst, Buus, Søren & Claesson, Mogens Helweg, 2006, In: Cancer Letters. 231, 2, p. 247-56 9 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    5. 2003
    6. Published

      Immunobiological Effects of Glucosamine In Vitro

      Forchhammer, L., Thorn, M., Met, Özcan, Gad, M., Weidner, M. S. & Claesson, Mogens Helweg, 1 Oct 2003, In: Scandinavian Journal of Immunology. 58, 4, p. 404-11 8 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    7. Published

      Peptide-loaded dendritic cells prime and activate MHC-class I-restricted T cells more efficiently than protein-loaded cross-presenting DC

      Met, Özcan, Buus, Søren & Claesson, Mogens Helweg, 2003, In: Cellular Immunology. 222, 2, p. 126-33 7 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    Previous 1...4 5 6 7 8 Next

    ID: 33971757